Tuesday, November 19, 2013
MetroHealth introduces MRI-guided biopsy to Northern Ohio
(Cleveland) – The MetroHealth System is now offering MRI-guided prostate biopsy using DynaTRIM, a new technology for diagnosing prostate cancer and the only FDA approved device for MRI-guided prostate biopsy. The health system is the only one in Northern Ohio offering the procedure.
Performing a biopsy with DynaTRIM reduces the number of tissue samples acquired, and thus reduces the risk of infection, bleeding, pain and recovery time compared to the traditional method.
“MetroHealth is really taking the lead in prostate cancer care by offering this service. We can now target suspicious areas in a way that was previously not available.” says Timothy Kasprzak, MD, Director of Oncologic and Abdominal Imaging.
When a physician suspects a man has prostate cancer, a traditional ultrasound prostate biopsy is done to take many samples of the prostate tissue. If the ultrasound results are negative, yet other findings suggest prostate cancer, MRI-guided biopsy can be used to detect and diagnose prostate cancer.
A removable device, DynaTRIM is designed to fasten to an MR imaging table with an open design that allows for flexibility for extra patient comfort. DynaTRIM enables physicians to conduct targeted MRI interventions of suspicious areas within the prostate gland.
According to the American Cancer Society, prostate cancer is one of the most common cancers in American men. One in 6 men will be diagnosed with prostate cancer during his lifetime. Prostate cancer is the second leading cause of cancer death in men behind lung cancer.
About The MetroHealth System
The MetroHealth System is a public health system committed to providing health care to everyone in Cuyahoga County, Ohio, and improving the health of the community overall. Its 6,000 employees deliver care to everyone at its main campus, just west of downtown Cleveland, and at 16 community health centers. MetroHealth is home to Cuyahoga County’s only Adult Level I Trauma Center and Comprehensive Burn Care Center. In the past year, MetroHealth provided more than one million patient visits in its hospital and community health centers.
MetroHealth is also an academic medical center committed to teaching and research; each of its active physicians holds a faculty appointment at Case Western Reserve University School of Medicine. MetroHealth has earned Magnet status, which places it in the top seven percent of all hospitals nationwide for nursing excellence.
MetroHealth’s mission is “Leading the way to a healthier you and a healthier community through service, teaching, discovery and teamwork." For more information, visit www.metrohealth.org